Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Haluzík

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Casopis Lekaru Ceskych|March 17, 2011
[Hyperglycemia and its control in the critically ill patient]Tomás Kotulák, Hynek Ríha, Martin Haluzík
Diabetes, Obesity & Metabolism|July 28, 2025
Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonistLuděk Horváth, Peter Novodvorský, Martin Haluzík
Drug Safety|November 14, 2014
Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effectsMartin Haluzík, Miloš Mráz, Štěpán Svačina
Protoplasma|February 3, 2017
Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?Anna Cinkajzlová, Miloš Mráz, Martin Haluzík
The Journal of Endocrinology|September 30, 2021
Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseasesAnna Cinkajzlová, Miloš Mráz, Martin Haluzík
Drugs & Aging|November 8, 2024
Pharmacological Treatment of Obesity in Older AdultsOndřej Žižka, Martin Haluzík, Edward B Jude
Advances in Therapy|May 3, 2022
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative ReviewMojca Jensterle, Manfredi Rizzo, Martin Haluzík, et al.
Casopis Lekaru Ceskych|December 10, 2020
Obesity treatment in patients both with and without diabetes: current options and perspectivesMartin Haluzík, Viktorie Hrádková, Michaela Kudláčková, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes MellitusAndrej Janež, Rok Ješe, Martin Haluzík, et al.
The Journal of Endocrinology|January 31, 2018
Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventionsMartin Haluzík, Helena Kratochvílová, Denisa Haluzíková, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Casopis Lekaru Ceskych|March 17, 2011
[Hyperglycemia and its control in the critically ill patient]Tomás Kotulák, Hynek Ríha, Martin Haluzík
Diabetes, Obesity & Metabolism|July 28, 2025
Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonistLuděk Horváth, Peter Novodvorský, Martin Haluzík
Drug Safety|November 14, 2014
Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effectsMartin Haluzík, Miloš Mráz, Štěpán Svačina
Protoplasma|February 3, 2017
Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?Anna Cinkajzlová, Miloš Mráz, Martin Haluzík
The Journal of Endocrinology|September 30, 2021
Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseasesAnna Cinkajzlová, Miloš Mráz, Martin Haluzík
Drugs & Aging|November 8, 2024
Pharmacological Treatment of Obesity in Older AdultsOndřej Žižka, Martin Haluzík, Edward B Jude
Advances in Therapy|May 3, 2022
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative ReviewMojca Jensterle, Manfredi Rizzo, Martin Haluzík, et al.
Casopis Lekaru Ceskych|December 10, 2020
Obesity treatment in patients both with and without diabetes: current options and perspectivesMartin Haluzík, Viktorie Hrádková, Michaela Kudláčková, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes MellitusAndrej Janež, Rok Ješe, Martin Haluzík, et al.
The Journal of Endocrinology|January 31, 2018
Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventionsMartin Haluzík, Helena Kratochvílová, Denisa Haluzíková, et al.
Pageof 12